Hundreds of lawsuits filed on "weight loss" drugmakers over vision loss compliants
- Hundreds of Americans have filed lawsuits against Novo Nordisk and Eli Lilly, alleging insufficient warnings about vision loss due to GLP 1 drugs.
- The lawsuits allege that patients were not adequately informed about potential dangers associated with GLP-1 medications.
- Novo Nordisk said it is vigorously contesting the lawsuits, asserting that the claims are without merit and unfounded.
- Eli Lilly said ensuring patient safety remains its top priority amid ongoing legal challenges related to GLP-1 drugs.
Source: nbcnews.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
